Patent details

EP4069254 Title: SOLID ORAL DOSAGE FORMS COMPRISING DECITABINE AND CEDAZURIDINE

Basic Information

Publication number:
EP4069254
PCT Application Number:
US2021019310
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP217618834
PCT Publication Number:
WO2021173598
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SOLID ORAL DOSAGE FORMS COMPRISING DECITABINE AND CEDAZURIDINE
French Title of Invention:
FORMES POSOLOGIQUES ORALES SOLIDES COMPRENANT DE LA DECITABINE ET DE LA CÉDAZURIDINE
German Title of Invention:
FESTE ORALE DARREICHUNGSFORMEN MIT DECITABIN UND CEDAZURIDIN
SPC Number:

Dates

Filing date:
24/02/2021
Grant date:
11/09/2024
EP Publication Date:
12/10/2022
PCT Publication Date:
02/09/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/09/2024
EP B1 Publication Date:
11/09/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/02/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/09/2024
 
 

Name:
Otsuka Pharmaceutical Co., Ltd.
Address:
2-9, Kanda Tsukasa-machi Chiyoda-ku, Tokyo 101-8535, Japan (JP)

Agent

Name:
VALIPAT
From:
17/09/2024
Address:
Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)
To:

Inventor

1

Name:
OGANESIAN, Aram
Address:
United States (US)

2

Name:
KOU, Jim Hwaicher
Address:
United States (US)

3

Name:
DAVAR, Nipun
Address:
United States (US)

Priority

Priority Number:
202062981304 P
Priority Date:
25/02/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/706; A61K 31/7068; A61P 35/00; A61P 35/02;

Publication

European Patent Bulletin

Issue number:
202437
Publication date:
11/09/2024
Description:
Grant (B1)

Deed

Power of attorney

Change Kind/ Decision Type:
Assignment
Deed Number:
RC20240000394A
Date Registered:
17/09/2024
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
VALIPAT
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Expected Payer:
Last Annual Fee Payment Date:
17/02/2025
Last Annual Fee Paid Number:
5
Last Annual Fee Paid Amount:
52 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
17/09/2024 Request For Change 2
17/09/2024 Outgoing Correspondence 1